1. 4. Muscle excitability in Myotonic Dystrophy type 1. Issue 3 (March 2016) Authors: Boland-Freitas, R.; Howells, J.; Liang, C.; Corbett, A.; Ng, K. Journal: Clinical neurophysiology Issue: Volume 127:Issue 3(2016:Mar.) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 8. Predicting motor disorders from nerve excitability studies. Issue 4 (April 2018) Authors: Li, T.; Howells, J.; Lin, C.S.Y.; Garg, N.; Kiernan, M.C.; Park, S.B. Journal: Clinical neurophysiology Issue: Volume 129:Issue 4(2018:Apr.) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conduction block in immune‐mediated neuropathy: paranodopathy versus axonopathy. (26th April 2019) Authors: Garg, N.; Park, S. B.; Howells, J.; Vucic, S.; Yiannikas, C.; Mathey, E. K.; Nguyen, T.; Noto, Y.; Barnett, M. H.; Krishnan, A. V.; Spies, J.; Bostock, H.; Pollard, J. D.; Kiernan, M. C. Journal: European journal of neurology Issue: Volume 26:Number 8(2019) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis. (9th October 2020) Authors: Dharmadasa, T.; Howells, J.; Matamala, J. M.; Simon, N. G.; Burke, D.; Vucic, S.; Kiernan, M. C. Journal: European journal of neurology Issue: Volume 28:Number 1(2021) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Experience with Vinorelbine in Patients with Breast Cancer and Hyperbilirubinaemia Secondary to Liver Metastases. Issue 8 (August 2020) Authors: Howells, J.; Gyi, M.; Blaiklock, E.; Gulliford, T.; Bradley, K.; Gale, J.; Archer, C.; Coyle, C. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevalence of incidental interstitial lung disease in the Manchester lung cancer screening pilot. (January 2019) Authors: Balata, H.; Hayton, C.; Barber, P.V.; Duerden, R.; Evison, M.; Greaves, M.; Howells, J.; Irion, K.; Karunaratne, D.; Leonard, C.; Mellor, S.; Newton, T.; Sawyer, R.; Sharman, A.; Smith, E.; Taylor, B.; Walsham, A.; Whittaker, J.; Chaudhuri, N.; Booton, R. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeted lung cancer screening selects individuals at high risk of cardiovascular disease. (October 2018) Authors: Balata, H.; Blandin Knight, S.; Barber, P.; Colligan, D.; Crosbie, E.J.; Duerden, R.; Elton, P.; Evison, M.; Greaves, M.; Howells, J.; Irion, K.; Karunaratne, D.; Kirwan, M.; Macnab, A.; Mellor, S.; Miller, C.; Newton, T.; Novasio, J.; Sawyer, R.; Sharman, A. Journal: Lung cancer Issue: Volume 124(2018) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗